- Investopedia•12 hours ago
Pfizer is planning to exit the Brazilian market as it puts its generic drug joint venture stake up for sale. Teva and Mylan are possible bidders for the asset.
- TheStreet.com•2 days ago
Teva Pharmaceuticals (TEVA) stock is rising in early morning trading today after the company won antitrust approval to purchase Allergan's (AGN) generics business.
Teva Pharmaceutical Industries LimitedNYSE
After hours: 53.570.07 (0.13%) as of 5:45 PM EDT
|Bid||53.61 x 100|
|Ask||53.74 x 100|
|52wk Range||48.01 - 71.68|
|Day's Range||53.33 - 54.83|
|Avg Vol (3m)||6,217,103|
As of 4:00 PM EDT. Market closed.